These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24149175)

  • 1. Comparison of TNM staging systems for nasopharyngeal carcinoma, and proposal of a new staging system.
    OuYang PY; Su Z; Ma XH; Mao YP; Liu MZ; Xie FY
    Br J Cancer; 2013 Dec; 109(12):2987-97. PubMed ID: 24149175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial.
    Kitpanit S; Jittapiromsak N; Sriyook A; Prayongrat A; Kannarunimit D; Chakkabat C; Lertbutsayanukul C
    Jpn J Clin Oncol; 2019 Dec; 49(12):1100-1113. PubMed ID: 31334768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era.
    Tang LL; Chen YP; Mao YP; Wang ZX; Guo R; Chen L; Tian L; Lin AH; Li L; Sun Y; Ma J
    J Natl Compr Canc Netw; 2017 Jul; 15(7):913-919. PubMed ID: 28687579
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation and suggestion of eighth T classifications of the UICC/AJCC staging system for nasopharyngeal carcinoma patients: a retrospective analysis.
    Li Y; Ou X; Hu C
    Jpn J Clin Oncol; 2018 Oct; 48(10):927-933. PubMed ID: 30113640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.
    Li J; Zou X; Wu YL; Guo JC; Yun JP; Xu M; Feng QS; Chen LZ; Bei JX; Zeng YX; Chen MY
    PLoS One; 2014; 9(12):e116261. PubMed ID: 25536307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.
    Wu LR; Zhang XM; Xie XD; Lu Y; Wu JF; He X
    Oral Oncol; 2019 Nov; 98():141-146. PubMed ID: 31586896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal colorectal cancer staging criteria in TNM classification.
    Ueno H; Mochizuki H; Akagi Y; Kusumi T; Yamada K; Ikegami M; Kawachi H; Kameoka S; Ohkura Y; Masaki T; Kushima R; Takahashi K; Ajioka Y; Hase K; Ochiai A; Wada R; Iwaya K; Shimazaki H; Nakamura T; Sugihara K
    J Clin Oncol; 2012 May; 30(13):1519-26. PubMed ID: 22430272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasopharyngeal carcinoma in a non-endemic country-Validation of the new NPC staging system.
    Rodrigues Dias D; Breda E; Sousa F; Soares A; Monteiro E
    Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(1):39-49. PubMed ID: 36858784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Chan LL; O'Sullivan B; Lin SJ; Sze HC; Chen YB; Choi HC; Guo QJ; Kan WK; Xiao YP; Wei X; Le QT; Glastonbury CM; Colevas AD; Weber RS; Shah JP; Lee AW
    Cancer; 2016 Feb; 122(4):546-58. PubMed ID: 26588425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suggestions for lymph node classification of UICC/AJCC staging system: a retrospective study based on 1197 nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
    Guo Q; Pan J; Zong J; Zheng W; Zhang C; Tang L; Chen B; Cui X; Xiao Y; Chen Y; Lin S
    Medicine (Baltimore); 2015 May; 94(20):e808. PubMed ID: 25997052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma.
    Pan J; Xu Y; Qiu S; Zong J; Guo Q; Zhang Y; Lin S; Lu JJ
    Am J Clin Oncol; 2015 Apr; 38(2):189-96. PubMed ID: 23608833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depicting distant metastatic risk by refined subgroups derived from the 8th edition nasopharyngeal carcinoma TNM.
    Guo Q; Lu T; Hui Huang S; O'Sullivan B; Zong J; Xiao Y; Xu W; Chen C; Qiu S; Xu L; Zheng W; Chen Y; Lin S; Pan J
    Oral Oncol; 2019 Apr; 91():113-120. PubMed ID: 30926056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
    Wu S; Xia B; Han F; Xie R; Song T; Lu L; Yu W; Deng X; He Q; Zhao C; Xie C
    PLoS One; 2015; 10(8):e0134491. PubMed ID: 26248338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Lee SW; Choi HC; Chan LL; Lin SJ; Guo QJ; Sze HC; Chen YB; Xiao YP; Kan WK; O'Sullivan B; Xu W; Le QT; Glastonbury CM; Colevas AD; Weber RS; Lydiatt W; Shah JP; Lee AW
    Cancer; 2016 Nov; 122(21):3307-3315. PubMed ID: 27434142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
    Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
    BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Added value of metastatic cervical lymph node group V in nodal staging of nasopharyngeal cancer.
    Setakornnukul J; Thephamongkhol K; Chaysiri P
    Head Neck; 2020 Oct; 42(10):2801-2810. PubMed ID: 32542997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
    Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
    Zhang L; Tang LQ; Chen QY; Liu H; Guo SS; Liu LT; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Shao JY; Sun Y; Ma J; Hong MH; Mai HQ
    Oncotarget; 2016 Feb; 7(5):6221-30. PubMed ID: 26716900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the 7th and 8th editions of UICC/AJCC staging system for nasopharyngeal carcinoma in the IMRT era.
    He T; Yan RN; Chen HY; Zeng YY; Xiang ZZ; Liu F; Shao BF; Ma JC; Wang XR; Liu L
    BMC Cancer; 2021 Mar; 21(1):327. PubMed ID: 33785010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.